Business profile

TRT Pharma Oy

TRT Pharma Oy's registered office is Helsingfors. It is a limited company. The company was established on 2015-01-02. It operates in the industry of retail sale of cosmetic and toilet articles. In its latest retained statement for 2024-12-31, revenue was €0 and operating profit was -€4,531.

Business ID 2659698-1ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
2659698-1
Sector
Retail sale of cosmetic and toilet articles
Municipality
Helsingfors
Company form
Limited company
Registration date
2015-01-02
Business ID registration date
2014-12-10
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Ulvilantie 20 F 72, 00350, Helsingfors

About TRT Pharma Oy

Financial position and key figures for the company.

TRT Pharma Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2015-01-02. It operates in the industry of retail sale of cosmetic and toilet articles. In its latest retained statement for 2024-12-31, revenue was €0 and operating profit was -€4,531. The latest retained financial statement for 2024-12-31 shows revenue of €0 and profit for the financial year of -€1,232. Based on the latest retained statement, revenue growth was -100.0%, operating margin was not currently available, and equity ratio was +100.0%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2024-12-31

Imported periods3
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth-100.0%
Equity ratio100.0%
Revenue€0-€1,164,452 (-100.0%) vs previous periodPrevious: €1,164,452
Operating profit (loss)-€4,531-€291,653 (-101.6%) vs previous periodPrevious: €287,122
Profit (loss) for the financial year-€1,232-€301,023 (-100.4%) vs previous periodPrevious: €299,791
Assets€2,627,790-€302,793 (-10.3%) vs previous periodPrevious: €2,930,583
Balance-sheet contextLatest financial period
Cash and bank€21,020Previous: €2,413,495
Retained earnings€2,626,523Previous: €2,554,732
Equity€2,627,790Previous: €2,857,023
Liabilities€0Previous: €73,560
Current assets€2,627,790Previous: €2,930,583
Current liabilities€0Previous: €73,560
Revenue trend2 periods
€1,164,452
2023-12-31
€0
2024-12-31
Operating profit (loss) trend2 periods
€287,122
2023-12-31
-€4,531
2024-12-31
Profit (loss) for the financial year trend2 periods
€299,791
2023-12-31
-€1,232
2024-12-31
Assets trend2 periods
€2,930,583
2023-12-31
€2,627,790
2024-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
100.0 %2023-12-31: 97.5 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2023-12-31: 32.81x
Operating profit marginNot assessable
0/100 · Trend unavailable
Not available2023-12-31: 24.7 %
Ratio history
Ratio2023-12-312024-12-31
Equity ratio97.5 %100.0 %
Current ratio32.81x-
Operating profit margin24.7 %-

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID2659698-1
EU IDFIFPRO.2659698-1
MunicipalityHelsingfors
Current registered entries
2015-01-02Registered in Patent and Registration Office (Trade Register)
2015-01-26Registered in Tax Administration (Tax Administration)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B1
StableTRT Pharma Oy
Grade unchangedB1 · new analysis 2026-10-04
Model score67/100
Assessment confidenceLow
Evidence qualityUsable financial evidenceFinancial data included
Financial trajectoryFinancial development is mostly stable or mixed.
3 comparable periods
RevenueDeteriorating
ProfitabilityNot enough history
SolvencyStable
LiquidityNot enough history
Peer comparisonSame size nationallyDescriptive comparison – does not change the model score.
358 peers
Solvency97%
Better than 97% of peers
Revenue growth3%
Below 97% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
3 observed filings
Latest registration lag140 days after period end
Typical registration lag133 days after period end
Annual continuity3 consecutive periods
Supporting factors
  • Strong equity ratio
  • Company context reduces the weight of an isolated financial signal
  • Active registered status
Risk factors to note
  • Negative profitability or net result
  • Sharp year-over-year revenue drop
  • Elevated industry distress context
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
4 assessments
B1
2026-10-04 18:2067/100 · v0.14
B1 → B1 · +2 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2024-12-31).
  • Assessment confidence: Medium → Low.
  • Evidence quality: Registry and statistical evidence → Usable financial evidence.
B1
2026-09-1565/100 · v0.14
B2 → B1 · +6 points
  • Assessment confidence: Low → Medium.
  • Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
  • New risk factor: Sufficient structured financial metrics are not available.
B2
2026-09-1459/100 · v0.12
Oldest retained automatic assessment in this comparison
Automatic model gradeB1
Automatic model snapshot2026-10-04
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
46/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityVakiintunut
80/100

The company has about 11 years of registry continuity.

Registry and status signalsSeurattava
74/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.

Registry timeline

Trade register notifications shown on a timeline.

20 register eventsLatest event: 2025-05-22

Financial statements availability

Available financial statement periods and PRH source filings.

3 financial statement periodsLatest financial period: 2024-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

TRT Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.